View Filing Data

Print Document View Excel Document

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Sep. 30, 2017	Oct. 30, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Trading Symbol	HAIN
Entity Registrant Name	HAIN CELESTIAL GROUP INC.
Entity Central Index Key	0000910406
Current Fiscal Year End Date	--06-30
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		103,791,688

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
ASSETS
Cash and cash equivalents	$ 126,787	$ 146,992
Accounts receivable, less allowance for doubtful accounts of $736 and $1,447, respectively	272,341	248,436
Inventories	484,792	427,308
Prepaid expenses and other current assets	60,976	52,045
Total current assets	944,896	874,781
Property, plant and equipment, net	380,478	370,511
Goodwill	1,073,681	1,059,981
Trademarks and other intangible assets, net	578,419	573,268
Investments and joint ventures	19,109	18,998
Other assets	35,264	33,565
Total assets	3,031,847	2,931,104
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable	247,321	222,136
Accrued expenses and other current liabilities	111,746	108,514
Current portion of long-term debt	18,231	9,844
Total current liabilities	377,298	340,494
Long-term debt, less current portion	746,392	740,304
Deferred income taxes	124,166	121,475
Other noncurrent liabilities	16,460	15,999
Total liabilities	1,264,316	1,218,272
Commitments and contingencies
Stockholders’ equity:
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none	0	0
Common stock - $.01 par value, authorized 150,000 shares; issued: 108,087 and 107,989 shares, respectively; outstanding: 103,748 and 103,702 shares, respectively	1,081	1,080
Additional paid-in capital	1,140,887	1,137,724
Retained earnings	888,668	868,822
Accumulated other comprehensive loss	(161,692)	(195,479)
Total stockholders' equity including treasury stock	1,868,944	1,812,147
Less: Treasury stock, at cost, 4,339 and 4,287 shares, respectively	(101,413)	(99,315)
Total stockholders’ equity	1,767,531	1,712,832
Total liabilities and stockholders’ equity	$ 3,031,847	$ 2,931,104

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts (in dollars)	$ 736	$ 1,447
Preferred stock, par value (USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	108,087,000	107,989,000
Common stock, shares, outstanding	103,748,000	103,702,000
Treasury stock, shares	4,339,000	4,287,000

Consolidated Statements Of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Net sales	$ 708,276	$ 681,464
Cost of sales	576,673	571,597
Gross profit	131,603	109,867
Selling, general and administrative expenses	90,721	84,967
Amortization of acquired intangibles	4,911	4,728
Acquisition related expenses, restructuring and integration charges	5,846	461
Accounting review costs, net of insurance proceeds	(1,358)	5,960
Operating income	31,483	13,751
Interest and other financing expense, net	6,315	5,081
Other (income)/expense, net	(3,137)	(512)
Income before income taxes and equity in net income of equity-method investees	28,305	9,182
Provision for income taxes	8,470	762
Equity in net income of equity-method investees	(11)	(184)
Net income	$ 19,846	$ 8,604
Net income per common share:
Basic (USD per share)	$ 0.19	$ 0.08
Diluted (USD per share)	$ 0.19	$ 0.08
Shares used in the calculation of net income per common share:
Basic (shares)	103,709	103,468
Diluted (shares)	104,476	104,206

Consolidated Statements Of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Statement of Comprehensive Income [Abstract]
Net income	$ 19,846	$ 8,604
Pre-tax amount
Foreign currency translation adjustments	33,861	(31,736)
Change in deferred gains (losses) on cash flow hedging instruments	(82)	(430)
Change in unrealized gain (loss) on available for sale investment	(10)	(57)
Total other comprehensive income (loss)	33,769	(32,223)
Tax (expense) benefit
Foreign currency translation adjustments	0	0
Change in deferred gains (losses) on cash flow hedging instruments	15	35
Change in unrealized gain (loss) on available for sale investment	3	17
Total other comprehensive income (loss)	18	52
After-tax amount
Foreign currency translation adjustments	33,861	(31,736)
Change in deferred gains (losses) on cash flow hedging instruments	(67)	(395)
Change in unrealized gain (loss) on available for sale investment	(7)	(40)
Net change in accumulated other comprehensive income (loss)	33,787	(32,171)
Total comprehensive income (loss)	$ 53,633	$ (23,567)

Consolidated Statement Of Stockholders' Equity (Unaudited) - 3 months ended Sep. 30, 2017 - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Jun. 30, 2017	$ 1,712,832	$ 1,080	$ 1,137,724	$ 868,822	$ (99,315)	$ (195,479)
Balance, shares at Jun. 30, 2017	107,989	107,989			4,287
Increase (Decrease) in Stockholders' Equity
Net income	$ 19,846			19,846
Other comprehensive income (loss)	33,787					33,787
Issuance of common stock pursuant to stock based compensation plans	0	$ 1	(1)
Issuance of common stock pursuant to stock based compensation plans, shares		98
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans	(2,098)				$ (2,098)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans, shares					52
Stock-based compensation expense	3,164		3,164
Balance at Sep. 30, 2017	$ 1,767,531	$ 1,081	$ 1,140,887	$ 888,668	$ (101,413)	$ (161,692)
Balance, shares at Sep. 30, 2017	108,087	108,087			4,339

Consolidated Statement Of Stockholders' Equity (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2017	Jun. 30, 2017
Statement of Stockholders' Equity [Abstract]
Common stock, par value (USD per share)	$ 0.01	$ 0.01

Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 19,846	$ 8,604
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	17,626	17,220
Deferred income taxes	(637)	(4,021)
Equity in net income of equity-method investees	(11)	(184)
Stock based compensation	3,164	2,704
Other non-cash items, net	(2,871)	(1,035)
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions:
Accounts receivable	(19,407)	18,569
Inventories	(51,840)	(37,707)
Other current assets	(7,919)	6,212
Other assets and liabilities	(389)	(439)
Accounts payable and accrued expenses	23,000	2,896
Net cash (used in) provided by operating activities	(19,438)	12,819
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment	(14,913)	(14,553)
Other	0	1,000
Net cash used in investing activities	(14,913)	(13,553)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility	20,000	22,000
Repayments under bank revolving credit facility	(15,000)	(26,500)
Borrowings (repayments) of other debt, net	8,185	(2,976)
Acquisition related contingent consideration	0	(2,498)
Shares withheld for payment of employee payroll taxes	(2,098)	(1,615)
Net cash provided by (used in) financing activities	11,087	(11,589)
Effect of exchange rate changes on cash	3,059	(2,131)
Net decrease in cash and cash equivalents	(20,205)	(14,454)
Cash and cash equivalents at beginning of period	146,992	127,926
Cash and cash equivalents at end of period	$ 126,787	$ 113,472

Business	3 Months Ended
Business	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business	BUSINESS The Hain Celestial Group, Inc., a Delaware corporation (collectively along with its subsidiaries, the “Company,” and herein referred to as “Hain Celestial,” “we,” “us” and “our”), was founded in 1993 and is headquartered in Lake Success, New York. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet — To Create and Inspire A Healthier Way of Life^TM and be the leading marketer, manufacturer and seller of organic and natural, “better-for-you” products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass market and e-commerce retailers, food service channels and club, drug and convenience stores in over 80 countries worldwide. With a proven track record of strategic growth and profitability, the Company manufactures, markets, distributes and sells organic and natural products under brand names that are sold as “better-for-you” products, providing consumers with the opportunity to lead A Healthier Way of Life^TM. Hain Celestial is a leader in many organic and natural products categories, with many recognized brands in the various market categories it serves, including Almond Dream^®, Arrowhead Mills^®, Bearitos^®, Better Bean^TM, BluePrint^®, Celestial Seasonings^®, Coconut Dream^®, Cully & Sully^®, Danival^®, DeBoles^®, Earth’s Best^®, Ella’s Kitchen^®, Empire^®, Europe’s Best^®, Farmhouse Fare^®, Frank Cooper’s^®, FreeBird^®, Gale’s^®, Garden of Eatin’^®, GG UniqueFiber^TM, Hain Pure Foods^®, Hartley’s^®, Health Valley^®, Imagine^®, Johnson’s Juice Co.^®, Joya^®, Kosher Valley^®, Lima^®, Linda McCartney’s^® (under license), MaraNatha^®, Natumi^®, New Covent Garden Soup Co.^®, Plainville Farms^®, Rice Dream^®, Robertson’s^®, Rudi’s Gluten-Free Bakery^®, Rudi’s Organic Bakery^®, Sensible Portions^®, Spectrum Organics^®, Soy Dream^®, Sun-Pat^®, SunSpire^®, Terra^®, The Greek Gods^®, Tilda^®, Walnut Acres^®, WestSoy^®, Yorkshire Provender^TM and Yves Veggie Cuisine^®. The Company’s personal care products are marketed under the Alba Botanica^®, Avalon Organics^®, Earth’s Best^®, JASON^®, Live Clean^® and Queen Helene^® brands. Changes in Segments Effective July 1, 2017, due to changes to the Company’s internal management and reporting structure, the United Kingdom operations of the Ella’s Kitchen^® brand (“Ella’s Kitchen UK”), which was previously included within the United States reportable segment, was moved to the United Kingdom reportable segment. See Note 15, Segment Information, for additional information on the Company’s operating and reportable segments.

Basis of Presentation

3 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Basis of Presentation

BASIS OF PRESENTATION

The Company’s unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP. The amounts as of and for the periods ended June 30, 2017 are derived from the Company’s audited annual financial statements. The unaudited consolidated financial statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair presentation for interim periods. Operating results for the three months ended September 30, 2017 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2018. Please refer to the Notes to the Consolidated Financial Statements as of June 30, 2017 and for the fiscal year then ended included in the Company’s Annual Report on Form 10-K (the “Form 10-K”) for information not included in these condensed notes.

All amounts in the unaudited consolidated financial statements, notes and tables have been rounded to the nearest thousand, except par values and per share amounts, unless otherwise indicated.

Newly Adopted Accounting Pronouncements

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. This ASU, among other things, changes the treatment of share-based payment transactions by recognizing the impact of excess tax benefits or deficiencies related to exercised or vested awards in income tax expense in the period of exercise or vesting, instead of additional paid in capital. The updated guidance is effective for fiscal years beginning after December 15, 2016 and interim periods within those annual periods. The Company adopted this new guidance effective July 1, 2017. As a result of this adoption:


•	As required, we prospectively recognized discrete tax benefits and deficiencies of $599 in the income tax line item of our consolidated income statement for the three months ended September 30, 2017 related to excess tax benefits upon vesting or settlement in that period.


•	We elected to adopt the cash flow presentation of the excess tax benefits retrospectively. As a result, we decreased our cash used in financing activities by $405 for the three months ended September 30, 2016.


•	We have elected to continue to estimate the number of stock-based awards expected to vest, rather than electing to account for forfeitures as they occur to determine the amount of compensation costs to be recognized in each period.


•	We have not changed our policy on statutory withholding requirements and will continue to allow an employee to withhold at the minimum statutory withholding requirements. Amounts paid by us to taxing authorities when directly withholding shares associated with employees’ income tax withholding obligations are classified as a financing activity in our cash flow statement.


•	We excluded the excess tax benefits from the assumed proceeds available to repurchase shares in the computation of our diluted earnings per share for the three months ended September 30, 2017.


•	We did not have any material excess tax benefits previously recognized in additional paid-in capital, therefore, it was not necessary to record a deferred tax asset for the unrecognized tax benefits with an adjustment to opening retained earnings.

Recently Issued Accounting Pronouncements Not Yet Effective

In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 revises accounting for operating leases by a lessee, among other changes, and requires a lessee to recognize a liability to make lease payments and an asset representing its right to use the underlying asset for the lease term in the balance sheet. The standard is effective for the first interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-02.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Under ASU 2014-09, an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. Subsequent to the issuance of ASU 2014-09, the FASB has issued various additional ASUs clarifying and amending this new revenue guidance. These ASUs apply to all companies that enter into contracts with customers to transfer goods or services and are effective for public entities for interim and annual reporting periods beginning after December 15, 2017. Early adoption is permitted. Entities have the choice to apply these ASUs either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying these standards at the date of initial application and not adjusting comparative information. The Company is currently evaluating the provisions of ASU No. 2014-09 and assessing the impact on its financial statements. As part of our assessment work-to-date, we have formed an implementation work team, begun training on the new ASU’s revenue recognition model and are beginning to review our customer contracts. We are also evaluating the impact of the new standard on certain common practices currently employed by the Company and by other manufacturers of consumer products, such as slotting fees, co-operative advertising, rebates and other pricing allowances, merchandising funds and consumer coupons. We have not yet determined if the full retrospective or modified retrospective method will be applied.

Refer to Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements as of June 30, 2017 and for the fiscal year then ended included in the Form 10-K for a detailed discussion on additional recently issued accounting pronouncements not yet adopted by the Company. There has been no change to the statements made in the Form 10-K as of the date of filing of this Form 10-Q.

Earnings Per Share

3 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:



	Three Months Ended September 30,
	2017		2016
Numerator:
Net income	$	19,846	$	8,604

Denominator:
Basic weighted average shares outstanding	103,709		103,468
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units	767		738
Diluted weighted average shares outstanding	104,476		104,206

Net income per common share:
Basic	$	0.19	$	0.08
Diluted	$	0.19	$	0.08

Basic earnings per share excludes the dilutive effects of stock options, unvested restricted stock and unvested restricted share units. Diluted earnings per share includes the dilutive effects of common stock equivalents such as stock options and unvested restricted stock awards.

There were 573 and 277 stock-based awards excluded from our diluted earnings per share calculations for the three months ended September 30, 2017 and 2016, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods. Additionally, 4 restricted stock awards were excluded from our diluted earnings per share calculation for the three months ended September 30, 2016 as such awards were antidilutive. Restricted stock awards excluded from our diluted earnings per share calculation for the three months ended September 30, 2017 were de minimis.

Share Repurchase Program

On June 21, 2017, the Company's Board of Directors authorized the repurchase of up to $250,000 of the Company’s issued and

outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations, including the Company’s historical strategy of pursuing accretive acquisitions. As of September 30, 2017, the Company had not repurchased any shares under this program, and had $250,000 of remaining capacity under the share repurchase program.

Acquisitions	3 Months Ended
Acquisitions	Sep. 30, 2017
Business Combinations [Abstract]
Acquisitions	ACQUISITIONS The Company accounts for acquisitions in accordance with ASC 805, Business Combinations. The results of operations of the acquisitions have been included in the consolidated results from their respective dates of acquisition. The purchase price of each acquisition is allocated to the tangible assets, liabilities and identifiable intangible assets acquired based on their estimated fair values. Acquisitions may include contingent consideration, the fair value of which is estimated on the acquisition date as the present value of the expected contingent payments, determined using weighted probabilities of possible payments. The fair values assigned to identifiable intangible assets acquired were determined primarily by using an income approach which was based on assumptions and estimates made by management. Significant assumptions utilized in the income approach were based on company-specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by authoritative guidance. The excess of the purchase price over the fair value of the identified assets and liabilities has been recorded as goodwill. The costs related to all acquisitions have been expensed as incurred and are included in “Acquisition related expenses, restructuring and integration charges” in the Consolidated Statements of Income. Acquisition-related costs of $114 and $253 were expensed in the three months ended September 30, 2017 and September 30, 2016, respectively. The expenses incurred primarily related to professional fees and other transaction-related costs associated with our recent acquisitions. Fiscal 2017 On June 19, 2017, the Company acquired Sonmundo, Inc. d/b/a The Better Bean Company (“Better Bean”), which offers prepared beans and bean-based dips sold in refrigerated tubs under the Better Bean^TM brand. Consideration for the transaction consisted of cash, net of cash acquired, totaling $3,434. Additionally, contingent consideration of up to a maximum of $4,000 is payable based on the achievement of specified operating results over the three-year period following the closing date. Better Bean is included in our Cultivate operating segment, which is part of Rest of World. Net sales and income before income taxes attributable to the Better Bean acquisition included in our consolidated results represented less than 1% of our consolidated results. On April 28, 2017, the Company acquired The Yorkshire Provender Limited (“Yorkshire Provender”), a producer of premium branded soups based in North Yorkshire in the United Kingdom. Yorkshire Provender supplies leading retailers, on-the-go food outlets and food service providers in the United Kingdom. Consideration for the transaction consisted of cash, net of cash acquired, totaling £12,465 (approximately $16,110 at the transaction date exchange rate). Additionally, contingent consideration of up to a maximum of £1,500 is payable based on the achievement of specified operating results at the end of the three-year period following the closing date. Yorkshire Provender is included in our United Kingdom operating and reportable segment. Net sales and income before income taxes attributable to Yorkshire Provender included in our consolidated results represented less than 1% of our consolidated results.

Inventories

3 Months Ended

Sep. 30, 2017

Inventory Disclosure [Abstract]

Inventories

INVENTORIES

Inventories consisted of the following:



	September 30, 2017		June 30, 2017
Finished goods	$	295,794	$	264,148
Raw materials, work-in-progress and packaging	188,998		163,160
	$	484,792	$	427,308

Property, Plant And Equipment, Net

3 Months Ended

Sep. 30, 2017

Property, Plant and Equipment [Abstract]

Property, Plant And Equipment, Net

PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net consisted of the following:



	September 30, 2017		June 30, 2017
Land	$	34,556	$	33,930
Buildings and improvements	118,553		116,723
Machinery and equipment	361,830		350,689
Computer hardware and software	52,740		51,486
Furniture and fixtures	16,480		15,993
Leasehold improvements	30,199		29,296
Construction in progress	22,907		16,119
	637,265		614,236
Less: Accumulated depreciation and amortization	256,787		243,725
	$	380,478	$	370,511

Depreciation and amortization expense for the three months ended September 30, 2017 and 2016 was $10,295 and $10,228, respectively.

Goodwill And Other Intangible Assets

3 Months Ended

Sep. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill And Other Intangible Assets

GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table shows the changes in the carrying amount of goodwill by business segment:



	United States			United Kingdom		Hain Pure Protein		Rest of World		Total
Balance as of June 30, 2017 (a)	$	591,416		$	329,135	$	41,089	$	98,341	$	1,059,981
Reallocation of goodwill between reporting units (b)	(35,519		)	35,519		—		—		—
Translation and other adjustments, net	—			10,785		—		2,915		13,700
Balance as of September 30, 2017 (a)	$	555,897		$	375,439	$	41,089	$	101,256	$	1,073,681

(a) The total carrying value of goodwill is reflected net of $126,577 of accumulated impairment charges, of which $97,358 related to the Company’s United Kingdom operating segment and $29,219 related to the Company’s Europe operating segment.

(b) Effective July 1, 2017, due to changes to the Company’s internal management and reporting structure, the United Kingdom operations of the Ella’s Kitchen^® brand, which was previously included within the United States reportable segment, was moved to the United Kingdom reportable segment. Goodwill totaling $35,519 was reallocated to the United Kingdom reportable segment in connection with this change. See Note 1, Business, and Note 15, Segment Information, for additional information on the Company’s operating and reportable segments.

The Company performs its annual test for goodwill and indefinite lived intangible asset impairment as of the first day of the fourth quarter of its fiscal year. In addition, if and when events or circumstances change that would more likely than not reduce the fair value of any of its reporting units or indefinite-life intangible assets below their carrying value, an interim test is performed.

The change in operating segments as described above was deemed a triggering event, resulting in the Company performing an interim goodwill impairment analysis on the reporting units impacted by this segment change as of immediately before and immediately after the change. There were no impairment indicators resulting from this analysis, and there were no impairment charges recorded during the three months ended September 30, 2017.

Other Intangible Assets

The following table sets forth balance sheet information for intangible assets, excluding goodwill, subject to amortization and intangible assets not subject to amortization:



	September 30, 2017			June 30, 2017
Non-amortized intangible assets:
Trademarks and tradenames (a)	$	431,321		$	424,817
Amortized intangible assets:
Other intangibles	253,087			247,712
Less: accumulated amortization	(105,989		)	(99,261		)
Net carrying amount	$	578,419		$	573,268

(a) The gross carrying value of trademarks and tradenames is reflected net of $60,202 of accumulated impairment charges.

Indefinite-lived intangible assets, which are not amortized, consist primarily of acquired trade names and trademarks. Indefinite-lived intangible assets are evaluated on an annual basis, in conjunction with the Company’s evaluation of goodwill. In assessing fair value, the Company utilizes a “relief from royalty” methodology. This approach involves two steps: (i) estimating the royalty rates for each trademark and (ii) applying these royalty rates to a projected net sales stream and discounting the resulting cash flows to determine fair value. If the carrying value of the indefinite-lived intangible assets exceeds the fair value of the asset, the carrying value is written down to fair value in the period identified. The result of this assessment for the fiscal year ended June 30, 2017 indicated that the fair value of certain of the Company’s tradenames was below their carrying value, and therefore an impairment charge of $14,079 ($7,579 in the United Kingdom segment and $6,500 in the United States segment) was recognized during the fiscal year ended June 30, 2017. There were no other impairment charges recorded during fiscal 2017, and no impairment charges were recorded during the three months ended September 30, 2017.

Amortizable intangible assets, which are deemed to have a finite life, primarily consist of customer relationships and are amortized over their estimated useful lives of 3 to 25 years. Amortization expense included in continuing operations was as follows:



	Three Months ended September 30,
	2017		2016
Amortization of intangible assets	$	4,911	$	4,728

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Debt and Borrowings

3 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Debt and Borrowings

DEBT AND BORROWINGS

Debt and borrowings consisted of the following:



	September 30, 2017		June 30, 2017
Credit Agreement borrowings payable to banks	$	739,678	$	733,715
Tilda short-term borrowing arrangements	16,490		7,761
Other borrowings	8,455		8,672
	764,623		750,148
Short-term borrowings and current portion of long-term debt	18,231		9,844
Long-term debt, less current portion	$	746,392	$	740,304

Credit Agreement

On December 12, 2014, the Company entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) which provides for a $1,000,000 unsecured revolving credit facility which may be increased by an additional uncommitted $350,000, provided certain conditions are met. The Credit Agreement expires in December 2019. Borrowings under the Credit Agreement may be used to provide working capital, finance capital expenditures and permitted acquisitions, refinance certain existing indebtedness and for other lawful corporate purposes. The Credit Agreement provides for multicurrency borrowings in Euros, Pounds Sterling and Canadian Dollars as well as other currencies which may be designated. In addition, certain wholly-owned foreign subsidiaries of the Company may be designated as co-borrowers. The Credit Agreement contains restrictive covenants, which are usual and customary for facilities of its type, and include, with specified exceptions, limitations on the Company’s ability to engage in certain business activities, incur debt, have liens, make capital expenditures, pay dividends or make other distributions, enter into affiliate transactions, consolidate, merge or acquire or dispose of assets, and make certain investments, acquisitions and loans. The Credit Agreement also requires the Company to satisfy certain financial covenants, such as maintaining a consolidated interest coverage ratio (as defined in the Credit Agreement) of no less than 4.0 to 1.0 and a consolidated leverage ratio (as defined in the Credit Agreement) of no more than 3.5 to 1.0. The consolidated leverage ratio is subject to a step-up to 4.0 to 1.0 for the four full fiscal quarters following an acquisition. Obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company. As of September 30, 2017, there were $739,678 of borrowings and $6,180 letters of credit outstanding under the Credit Agreement and $254,142 available, and the Company was in compliance with all associated covenants.

The Credit Agreement provides that loans will bear interest at rates based on (a) the Eurocurrency Rate, as defined in the Credit Agreement, plus a rate ranging from 0.875% to 1.70% per annum; or (b) the Base Rate, as defined in the Credit Agreement, plus a rate ranging from 0.00% to 0.70% per annum, the relevant rate being the Applicable Rate. The Applicable Rate will be determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. Swing line loans and Global Swing Line loans denominated in U.S, dollars will bear interest at the Base Rate plus the Applicable Rate, and Global Swing Line loans denominated in foreign currencies shall bear interest based on the overnight Eurocurrency Rate for loans denominated in such currency plus the Applicable Rate. The weighted average interest rate on outstanding borrowings under the Credit Agreement at September 30, 2017 was 2.88%. Additionally, the Credit Agreement contains a Commitment Fee, as defined in the Credit Agreement, on the amount unused under the Credit Agreement ranging from 0.20% to 0.30% per annum. Such Commitment Fee is determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement.

Tilda Short-Term Borrowing Arrangements

Tilda maintains short-term borrowing arrangements primarily used to fund the purchase of rice from India and other countries. The maximum borrowings permitted under all such arrangements are £52,000. Outstanding borrowings are collateralized by the current assets of Tilda, typically have six-month terms and bear interest at variable rates typically based on LIBOR plus a margin (weighted average interest rate of approximately 2.72% at September 30, 2017).

Other Borrowings

Other borrowings primarily relate to a cash pool facility in Europe. The cash pool facility provides our Europe operating segment with sufficient liquidity to support the Company’s growth objectives within this segment. The maximum borrowings permitted under the cash pool arrangement are €12,500. Outstanding borrowings bear interest at variable rates typically based on EURIBOR plus a margin of 1.10% (weighted average interest rate of approximately 1.10% at September 30, 2017).

Income Taxes Income Taxes	3 Months Ended
Income Taxes Income Taxes	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES The Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The Company’s effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements. The effective income tax rate was 29.9% and 8.3% for the three months ended September 30, 2017 and 2016, respectively. The effective tax rate for the three months ended September 30, 2017 and September 30, 2016 was favorable as compared to the statutory rate as a result of the geographical mix of earnings. The effective tax rate for the three months ended September 30, 2016 was also impacted by a reduction in the statutory tax rate in the United Kingdom enacted in the first quarter of fiscal 2017. Such reduction resulted in a decrease to the carrying value of net deferred tax liabilities of $2,086, which favorably impacted the effective tax rate.

Accumulated Other Comprehensive Income (Loss)

3 Months Ended

Sep. 30, 2017

Equity [Abstract]

Accumulated Other Comprehensive Income (Loss)

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following tables present the changes in accumulated other comprehensive income (loss):



	Three Months Ended September 30,
	2017			2016
Foreign currency translation adjustments:
Other comprehensive income (loss) before reclassifications ⁽¹⁾	$	33,861		$	(31,736	)
Deferred gains/(losses) on cash flow hedging instruments:
Other comprehensive income before reclassifications	39			101
Amounts reclassified into income ⁽²⁾	(106		)	(496		)
Unrealized gain/(loss) on available for sale investment:
Other comprehensive loss before reclassifications	(7		)	(50		)
Amounts reclassified into income ⁽³⁾	—			10
Net change in accumulated other comprehensive income (loss)	$	33,787		$	(32,171	)


(1)	Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature and were a gain of $751 and a loss of $7,152 for the three months ended September 30, 2017 and 2016, respectively.


(2)	Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were $132 and $620 for the three months ended September 30, 2017 and 2016, respectively.

(3)

Amounts reclassified into income for losses on sale of available for sale investments were based on the average cost of the shares held (See Note 12, Investments and Joint Ventures). Such amounts are recorded in “Other (income)/expense, net” in the Consolidated Statements of Income and were $16 before taxes for the three months ended September 30, 2016. There were no amounts reclassified into income for losses on sale of available for sale investments for the three months ended September 30, 2017.

Stock-Based Compensation And Incentive Performance Plans

3 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation And Incentive Performance Plans

STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS

The Company has two shareholder-approved plans, the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan and the 2000 Directors Stock Plan, under which the Company’s officers, senior management, other key employees, consultants and directors may be granted options to purchase the Company’s common stock or other forms of equity-based awards.

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Income for stock based compensation plans were as follows:



	Three Months Ended September 30,
	2017		2016
Compensation cost (included in selling, general and administrative expense)	$	3,164	$	2,704
Related income tax benefit	$	1,234	$	1,014

Stock Options

A summary of the stock option activity for the three months ended September 30, 2017 is as follows:



	Number of Options	Weighted Average Exercise Price		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
Options outstanding and exercisable at June 30, 2017	122	$	2.26
Exercised	—	$	—
Options outstanding and exercisable at September 30, 2017	122	$	2.26	13.8	$	4,742

At September 30, 2017, there was no unrecognized compensation expense related to stock option awards.

Restricted Stock

A summary of the restricted stock and restricted share unit activity for the three months ended September 30, 2017 is as follows:



	Number of Shares and Units		Weighted Average Grant Date Fair Value (per share)
Non-vested restricted stock, restricted share units, and performance units at June 30, 2017	992		$	27.59
Granted	352		$	32.75
Vested	(98	)	$	24.98
Forfeited	(4	)	$	33.95
Non-vested restricted stock, restricted share units, and performance units at September 30, 2017	1,242		$	29.24



	Three Months Ended September 30,
	2017		2016
Fair value of restricted stock and restricted share units granted	$	11,516	$	—
Fair value of shares vested	$	4,019	$	2,926
Tax benefit recognized from restricted shares vesting	$	1,567	$	1,139

On July 3, 2012, the Company entered into a Restricted Stock Agreement (the “Agreement”) with Irwin D. Simon, the Company’s Chairman, President and Chief Executive Officer. The Agreement provides for a grant of 800 shares of restricted stock (the “Shares”), the vesting of which is both market and time-based. The market condition is satisfied in increments of 200 Shares upon the Company’s common stock achieving four share price targets. On the last day of any forty-five consecutive trading day period during which the average closing price of the Company’s common stock on the Nasdaq Global Select Market equals or exceeds the following prices: $31.25, $36.25, $41.25 and $50.00, respectively, the market condition for each increment of 200 Shares will be satisfied. The market conditions were required to be satisfied prior to June 30, 2017. Once each market condition has been satisfied, a tranche of 200 Shares will vest in equal amounts annually over a five-year period. Except in the case of a change of control, termination without cause, death or disability (each as defined in Mr. Simon’s Employment Agreement), the unvested Shares are subject to forfeiture unless Mr. Simon remains employed through the applicable market conditions and time vesting periods. The grant date fair value for each tranche was separately estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment and the time frame most likely for goal attainment. The total grant date fair value of the Shares was estimated to be $16,151, which was expected to be recognized over a weighted-average period of approximately 4.0 years. On September 28, 2012, August 27, 2013, December 13, 2013 and October 22, 2014, the four respective market conditions were satisfied. As such, the four tranches of 200 Shares each are expected to vest in equal amounts over the five-year period commencing on the first anniversary of the date the market condition for the respective tranche was satisfied.

At September 30, 2017, $19,737 of unrecognized stock-based compensation expense, net of estimated forfeitures, related to non-vested restricted stock awards, inclusive of the Shares, was expected to be recognized over a weighted-average period of approximately 1.9 years.

Long-Term Incentive Plan

The Company maintains a long-term incentive program (the “LTI Plan”). The LTI Plan currently consists of a two-year performance-based long-term incentive plan (the “2015-2016 LTIP”) and two performance-based long-term incentive plans (the “2016-2018 LTIP” and the “2017-2019 LTIP”) that provide for performance equity awards that can be earned over the respective three-year performance period. Participants in the LTI Plan include the Company’s executive officers, including the Chief Executive Officer, and certain other key executives.

The Compensation Committee administers the LTI Plan and is responsible for, among other items, selecting the specific performance measures for awards and setting the target performance required to receive an award after the completion of the performance period. The Compensation Committee determines the specific payout to the participants. Such awards may be paid in cash and/or unrestricted shares of the Company’s common stock at the discretion of the Compensation Committee, provided that any such stock-based awards shall be issued pursuant to and be subject to the terms and conditions of the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan, as in effect and as amended from time-to-time.

Upon the adoption of the 2015-2016 LTIP, the Compensation Committee granted an initial award to each participant in the form of equity-based instruments (restricted stock or restricted share units), for a portion of the individual target awards (the “Initial Equity Grants”). These Initial Equity Grants are subject to time vesting requirements, and a portion is also subject to the achievement of minimum performance goals. The 2015-2016 LTIP awards contain an additional year of time-based vesting. The Initial Equity Grants are expensed over the respective vesting periods on a straight-line basis. The payment of the actual awards earned at the end of the applicable performance period, if any, will be reduced by the value of the Initial Equity Grants.

Upon adoption of the 2016-2018 LTIP and 2017-2019 LTIP, the Compensation Committee granted performance units to each participant, the achievement of which is dependent upon a defined calculation of relative total shareholder return over the period from July 1, 2015 to June 30, 2018 and July 1, 2017 to June 30, 2019 (the “TSR Grant”), respectively. The grant date fair value for these awards was separately estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment. Each performance unit translates into one unit of common stock. The TSR grant represents half of each participant’s target award. The other half of the 2016-2018 LTIP and 2017-2019 LTIP is based on the Company’s achievement of specified net sales growth targets over the respective three-year period, if the targets are achieved, the award in connection with the 2016-2018 LTIP may be paid in cash and/or unrestricted shares of the Company’s common stock at the discretion of the Compensation Committee, while the award in connection with the 2017-2019 LTIP may be paid only in unrestricted shares of the Company’s common stock.

The Company recorded expense (in addition to the stock-based compensation expense associated with the Initial Equity Grants and the TSR Grant) of $546 and $1,127 for the three months ended September 30, 2017 and 2016, respectively, due to the Company’s current estimates of achievement under the plans.

Investments And Joint Ventures	3 Months Ended
Investments And Joint Ventures	Sep. 30, 2017
Equity Method Investments and Joint Ventures [Abstract]
Investments And Joint Ventures	INVESTMENTS AND JOINT VENTURES Equity method investments In October 2009, the Company formed a joint venture, Hutchison Hain Organic Holdings Limited (“HHO”), with Hutchison China Meditech Ltd. (“Chi-Med”), a majority-owned subsidiary of CK Hutchison Holdings Limited, to market and distribute certain of the Company’s brands in Hong Kong, China and other surrounding markets. Voting control of the joint venture is shared equally between the Company and Chi-Med, although, in the event of a deadlock, Chi-Med has the ability to cast the deciding vote, and therefore, the investment is being accounted for under the equity method of accounting. At September 30, 2017 and June 30, 2017, the carrying value of the Company’s 50.0% investment in and advances to HHO were $1,975 and $1,629, respectively, and are included in the Consolidated Balance Sheet as a component of “Investments and joint ventures.” On October 27, 2015, the Company acquired a 14.9% interest in Chop’t Creative Salad Company LLC (“Chop’t”). Chop’t develops and operates fast-casual, fresh salad restaurants in the Northeast and Mid-Atlantic United States. Chop’t markets and sells certain of the Company’s branded products and provides consumer insight and feedback. The investment is being accounted for as an equity method investment due to the Company’s representation on the Board of Directors. At September 30, 2017 and June 30, 2017, the carrying value of the Company’s investment in Chop’t was $16,262 and $16,487, respectively, and is included in the Consolidated Balance Sheet as a component of “Investments and joint ventures.” The Company’s current ownership percentage may be diluted in the future to 11.9%, pending the distribution of additional ownership interests. Available-For-Sale Securities The Company has a less than 1% equity ownership interest in Yeo Hiap Seng Limited (“YHS”), a Singapore-based natural food and beverage company listed on the Singapore Exchange, which is accounted for as an available-for-sale security. The shares held at September 30, 2017 totaled 933. The fair value of these shares held was $872 (cost basis of $1,164) at September 30, 2017 and $882 (cost basis of $1,164) at June 30, 2017 and is included in “Investments and joint ventures,” with the related unrealized gain or loss, net of tax, included in “Accumulated other comprehensive loss” in the Consolidated Balance Sheet. The Company concluded that the decline in its YHS investment below its cost basis is temporary and, accordingly, has not recognized a loss in the Consolidated Statements of Operations. In making this determination, the Company considered its intent and ability to hold the investment until the cost is recovered, the financial condition and near-term prospects of YHS, the magnitude of the loss compared to the investment’s cost, and publicly available information about the industry and geographic region in which YHS operates.

Financial Instruments Measured At Fair Value

3 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Financial Instruments Measured At Fair Value

FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE

The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:


•	Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;


•	Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and


•	Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of September 30, 2017:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	7,658	$	7,658	$	—	$	—
Forward foreign currency contracts	66		—		66		—
Available for sale securities	872		872		—		—
	$	8,596	$	8,530	$	66	$	—
Liabilities:
Forward foreign currency contracts	217		—		217		—
Contingent consideration, current	2,853		—		—		2,853
Total	$	3,070	$	—	$	217	$	2,853

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2017:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	21,800	$	21,800	$	—	$	—
Forward foreign currency contracts	99		—		99		—
Available for sale securities	882		882		—		—
	$	22,781	$	22,682	$	99	$	—
Liabilities:
Forward foreign currency contracts	$	53	$	—	$	53	$	—
Contingent consideration, current	$	2,656	$	—	$	—	$	2,656
Total	$	2,709	$	—	$	53	$	2,656

Available for sale securities consist of the Company’s investment in YHS (see Note 12, Investments and Joint Ventures). Fair value is measured using the market approach based on quoted prices. The Company utilizes the income approach to measure fair value for its foreign currency forward contracts. The income approach uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices.

The Company estimates the original fair value of the contingent consideration as the present value of the expected contingent payments, determined using the weighted probabilities of the possible payments. The Company reassesses the fair value of contingent payments on a periodic basis. Although the Company believes its estimates and assumptions are reasonable, different assumptions, including those regarding the operating results of the respective businesses, or changes in the future may result in different estimated amounts.

The following table summarizes the Level 3 activity for the three months ended September 30, 2017.



Balance as of June 30, 2017	$	2,656
Contingent consideration adjustment ^(a)	174
Translation adjustment	23
Balance as of September 30, 2017	$	2,853

(a) The change in the fair value of contingent consideration is included in “Acquisition related expenses, restructuring and integration charges” in the Company’s Consolidated Statements of Income.

There were no transfers of financial instruments between the three levels of fair value hierarchy during the three months ended September 30, 2017 or September 30, 2016.

The carrying amount of cash and cash equivalents, accounts receivable, net, accounts payable and certain accrued expenses and other current liabilities approximate fair value due to the short-term maturities of these financial instruments. The Company’s debt approximates fair value due to the debt bearing fluctuating market interest rates (See Note 8, Debt and Borrowings).

Derivative Instruments

The Company primarily has exposure to changes in foreign currency exchange rates relating to certain anticipated cash flows and firm commitments from its international operations. The Company may enter into certain derivative financial instruments, when available on a cost-effective basis, to manage such risk. Derivative financial instruments are not used for speculative purposes. The fair value of these derivatives is included in prepaid expenses and other current assets and accrued expenses and other current liabilities in the Consolidated Balance Sheet. For derivative instruments that qualify as hedges of probable forecasted cash flows, the effective portion of changes in fair value is temporarily reported in accumulated other comprehensive income and recognized in earnings when the hedged item affects earnings. Fair value hedges and derivative instruments not designated as hedges are marked-to-market each reporting period with any unrealized gains or losses recognized in earnings.

Derivative instruments designated at inception as hedges are measured for effectiveness at the inception of the hedge and on a quarterly basis. These assessments determine whether derivatives designated as qualifying hedges continue to be highly effective in offsetting changes in the cash flows of hedged items. Any ineffective portion of change in fair value is not deferred in accumulated other comprehensive income and is included in current period results. The Company will discontinue cash flow hedge accounting when the forecasted transaction is no longer probable of occurring on the originally forecasted date or when the hedge is no longer effective. There were no discontinued foreign exchange hedges for the three months ended September 30, 2017 and September 30, 2016.

There were no cash flow hedges outstanding as of September 30, 2017. The notional and fair value amounts of cash flow hedges at June 30, 2017 were $1,828 and $84 of net assets, respectively. The notional and fair value amounts of derivatives designated as fair value hedges at September 30, 2017 were $6,000 and $46 of net liabilities, respectively. There were no fair value hedges outstanding as of June 30, 2017.

The notional and fair value amounts of derivatives not designated as hedges at September 30, 2017 were $13,200 and $105 of net liabilities, respectively. There were $6,114 of notional amount and $38 of net liabilities of derivatives not designated as hedges as of June 30, 2017.

Gains and losses related to both designated and non-designated foreign currency exchange contracts are recorded in the Company’s Consolidated Statements of Operations based upon the nature of the underlying hedged transaction and were not material for the three months ended September 30, 2017 or September 30, 2016.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Commitments And Contingencies	3 Months Ended
Commitments And Contingencies	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	COMMITMENTS AND CONTINGENCIES Securities Class Actions Filed in Federal Court On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The three complaints are: (1) Flora v. The Hain Celestial Group, Inc., et al., (the “Flora Complaint”); (2) Lynn v. The Hain Celestial Group, Inc., et al. (the “Lynn Complaint”); and (3) Spadola v. The Hain Celestial Group, Inc., et al. (the “Spadola Complaint” and, together with the Flora and Lynn Complaints, the “Securities Complaints”). On June 5, 2017, the court issued an order for consolidation, appointment of Co-Lead Plaintiffs and approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation (the “Consolidated Securities Action”), and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs. On June 21, 2017, the Company received notice that plaintiff Spadola voluntarily dismissed his claims without prejudice to his ability to participate in the Consolidated Securities Action as an absent class member. The Co-Lead Plaintiffs in the Consolidated Securities Action filed a Consolidated Amended Complaint on August 4, 2017, and a Corrected Consolidated Amended Complaint on September 7, 2017 on behalf of a purported class consisting of all persons who purchased or otherwise acquired Hain Celestial securities between November 5, 2013 and February 10, 2017 (the “Amended Complaint”). The Amended Complaint names as defendants the Company and certain of its current and former officers (collectively, the “Defendants”) and asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls. Defendants filed a motion to dismiss on October 3, 2017. Co-Lead Plaintiffs’ opposition is due by December 4, 2017, and Defendants will file a reply within 45 days after the filing of the Lead Co-Plaintiffs’ opposition. Stockholder Derivative Complaints Filed in State Court On September 16, 2016, a stockholder derivative complaint, Paperny v. Heyer, et al. (the “Paperny Complaint”), was filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers of the Company alleging breach of fiduciary duty, unjust enrichment, lack of oversight and corporate waste. On December 2, 2016 and December 29, 2016, two additional stockholder derivative complaints were filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers under the captions Scarola v. Simon (the “Scarola Complaint”) and Shakir v. Simon (the “Shakir Complaint” and, together with the Paperny Complaint and the Scarola Complaint, the “Derivative Complaints”), respectively. Both the Scarola Complaint and the Shakir Complaint allege breach of fiduciary duty, lack of oversight and unjust enrichment. On February 16, 2017, the parties for the Derivative Complaints entered into a stipulation consolidating the matters under the caption In re The Hain Celestial Group (the “Consolidated Derivative Action”) in New York State Supreme Court in Nassau County, ordering the Shakir Complaint as the operative complaint. On November 2, 2017, the parties agreed to stay the Consolidated Derivative Action until April 11, 2018. Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court On April 19, 2017 and April 26, 2017, two class action and stockholder derivative complaints were filed in the Eastern District of New York against the Board of Directors and certain officers of the Company under the captions Silva v. Simon, et al. (the “Silva Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva Complaint and the Barnes Complaint allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment. On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the Board of Directors and certain officers of the Company. The complaint alleges that the Company’s directors and certain officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The complaint also alleges that the Company violated its by-laws and Delaware law by failing to hold its 2016 Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste. On August 9, 2017, the Court granted an order to unseal this case and reveal Gary Merenstein as the plaintiff. On August 10, 2017, the court granted the parties stipulation to consolidate the Barnes Compliant, the Silva Complaint and the Merenstein Compliant under the caption In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the “Consolidated Stockholder Class and Derivative Action”) and to appoint Robbins Arroyo LLP and Scott+Scott as Co-Lead Counsel, with the Law Offices of Thomas G. Amon as Liaison Counsel for Plaintiffs. On September 14, 2017, a related complaint was filed under the caption Oliver v. Berke, et al. (the “Oliver Complaint”), and on October 6, 2017, the Oliver Complaint was consolidated with the Consolidated Stockholder Class and Derivative Action. The Plaintiffs filed their consolidated amended complaint under seal on October 26, 2017. Defendants’ answer, motion, or other response to the consolidated amended complaint is due by December 26, 2017. SEC Investigation As previously disclosed, the Company voluntarily contacted the SEC in August 2016 to advise it of the Company’s delay in the filing of its periodic reports and the performance of the independent review conducted by the Audit Committee. The Company has continued to provide information to the SEC on an ongoing basis, including, among other things, the results of the independent review of the Audit Committee as well as other information pertaining to its internal accounting review relating to revenue recognition. On January 31, 2017, the SEC issued a subpoena to the Company seeking documents relevant to its investigation. The Company is in the process of responding to the SEC’s requests for information and intends to cooperate fully with the SEC. Other In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business. While the results of litigation and claims cannot be predicted with certainty, the Company believes the reasonably possible losses of such matters, individually and in the aggregate, are not material. Additionally, the Company believes the probable final outcome of such matters will not have a material adverse effect on the Company’s consolidated results of operations, financial position, cash flows or liquidity.

Segment Information

3 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATION

Prior to July 1, 2017, the Company’s operations were managed in eight operating segments: the United States, United Kingdom, Tilda, Hain Pure Protein Corporation (“HPPC”), EK Holdings, Inc. (“Empire”), Canada, Europe and Cultivate. The United States operating segment was also a reportable segment. The United Kingdom and Tilda operating segments were reported in the aggregate as “United Kingdom”, while HPPC and Empire were reported in the aggregate as “Hain Pure Protein,” and Canada, Europe and Cultivate were combined and reported as “Rest of World.”

Effective July 1, 2017, due to changes to the Company’s internal management and reporting structure, the United Kingdom operations of the Ella’s Kitchen^® brand, which was previously included within the United States reportable segment, was moved to the United Kingdom reportable segment. As a result, the Company is now managed in nine operating segments: the United States, United Kingdom, Tilda, Ella’s Kitchen UK, HPPC, Empire, Europe, Canada and Cultivate. Ella’s Kitchen UK is now combined with the United Kingdom and Tilda operating segments and is reported within the United Kingdom reportable segment. There were no changes to the Hain Pure Protein reportable segment or Rest of World. The prior period segment information contained below has been adjusted to reflect the Company’s new operating and reporting structure.

Net sales and operating income are the primary measures used by the Company’s Chief Operating Decision Maker (“CODM”) to evaluate segment operating performance and to decide how to allocate resources to segments. The CODM is the Company’s Chief Executive Officer. Expenses related to certain centralized administration functions that are not specifically related to an operating segment are included in “Corporate and Other.” Corporate and Other expenses are comprised mainly of the compensation and related expenses of certain of the Company’s senior executive officers and other selected employees who perform duties related to the entire enterprise, as well as expenses for certain professional fees, facilities, and other items which benefit the Company as a whole. Additionally, acquisition related expenses, restructuring and integration charges and other, along with accounting review costs, are included in “Corporate and Other.” Expenses that are managed centrally but can be attributed to a segment, such as employee benefits and certain facility costs, are allocated based on reasonable allocation methods. Assets are reviewed by the CODM on a consolidated basis and therefore are not reported by operating segment.

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.



	Three Months Ended September 30,
	2017			2016
Net Sales:
United States	$	263,659		$	254,232
United Kingdom	222,445			220,151
Hain Pure Protein	119,057			116,669
Rest of World	103,115			90,412
	$	708,276		$	681,464

Operating Income:
United States	$	20,861		$	18,794
United Kingdom	9,601			7,819
Hain Pure Protein	2,242			(1,018		)
Rest of World	8,997			5,055
	$	41,701		$	30,650
Corporate and Other ^(a)	(10,218		)	(16,899		)
	$	31,483		$	13,751

(a) Includes $4,488 and $6,421 of accounting review costs, net of insurance proceeds and acquisition related expenses, restructuring and integration charges for the three months ended September 30, 2017 and 2016, respectively.

The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic area are as follows:



	September 30, 2017		June 30, 2017
United States	$	196,087	$	194,348
United Kingdom	169,054		165,396
All Other	69,710		63,330
Total	$	434,851	$	423,074

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as follows:



	Three Months Ended September 30,
	2017		2016
United States	$	397,351	$	385,768
United Kingdom	222,445		220,151
All Other	88,480		75,545
Total	$	708,276	$	681,464

Basis of Presentation (Policies)

3 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Newly Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Effective

Newly Adopted Accounting Pronouncements


•	As required, we prospectively recognized discrete tax benefits and deficiencies of $599 in the income tax line item of our consolidated income statement for the three months ended September 30, 2017 related to excess tax benefits upon vesting or settlement in that period.


•	We elected to adopt the cash flow presentation of the excess tax benefits retrospectively. As a result, we decreased our cash used in financing activities by $405 for the three months ended September 30, 2016.


•	We have elected to continue to estimate the number of stock-based awards expected to vest, rather than electing to account for forfeitures as they occur to determine the amount of compensation costs to be recognized in each period.


•	We have not changed our policy on statutory withholding requirements and will continue to allow an employee to withhold at the minimum statutory withholding requirements. Amounts paid by us to taxing authorities when directly withholding shares associated with employees’ income tax withholding obligations are classified as a financing activity in our cash flow statement.


•	We excluded the excess tax benefits from the assumed proceeds available to repurchase shares in the computation of our diluted earnings per share for the three months ended September 30, 2017.


•	We did not have any material excess tax benefits previously recognized in additional paid-in capital, therefore, it was not necessary to record a deferred tax asset for the unrecognized tax benefits with an adjustment to opening retained earnings.

Recently Issued Accounting Pronouncements Not Yet Effective

Earnings Per Share (Tables)

3 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Computation Of Basic And Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share:



	Three Months Ended September 30,
	2017		2016
Numerator:
Net income	$	19,846	$	8,604

Denominator:
Basic weighted average shares outstanding	103,709		103,468
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units	767		738
Diluted weighted average shares outstanding	104,476		104,206

Net income per common share:
Basic	$	0.19	$	0.08
Diluted	$	0.19	$	0.08

Inventories (Tables)

3 Months Ended

Sep. 30, 2017

Inventory Disclosure [Abstract]

Components Of Inventories

Inventories consisted of the following:



	September 30, 2017		June 30, 2017
Finished goods	$	295,794	$	264,148
Raw materials, work-in-progress and packaging	188,998		163,160
	$	484,792	$	427,308

Property, Plant And Equipment, Net (Tables)

3 Months Ended

Sep. 30, 2017

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant and Equipment, Net

Property, plant and equipment, net consisted of the following:



	September 30, 2017		June 30, 2017
Land	$	34,556	$	33,930
Buildings and improvements	118,553		116,723
Machinery and equipment	361,830		350,689
Computer hardware and software	52,740		51,486
Furniture and fixtures	16,480		15,993
Leasehold improvements	30,199		29,296
Construction in progress	22,907		16,119
	637,265		614,236
Less: Accumulated depreciation and amortization	256,787		243,725
	$	380,478	$	370,511

Goodwill And Other Intangible Assets (Tables)

3 Months Ended

Sep. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Changes In Carrying Amount Of Goodwill

The following table shows the changes in the carrying amount of goodwill by business segment:



	United States			United Kingdom		Hain Pure Protein		Rest of World		Total
Balance as of June 30, 2017 (a)	$	591,416		$	329,135	$	41,089	$	98,341	$	1,059,981
Reallocation of goodwill between reporting units (b)	(35,519		)	35,519		—		—		—
Translation and other adjustments, net	—			10,785		—		2,915		13,700
Balance as of September 30, 2017 (a)	$	555,897		$	375,439	$	41,089	$	101,256	$	1,073,681

Components Of Trademarks And Other Intangible Assets

The following table sets forth balance sheet information for intangible assets, excluding goodwill, subject to amortization and intangible assets not subject to amortization:



	September 30, 2017			June 30, 2017
Non-amortized intangible assets:
Trademarks and tradenames (a)	$	431,321		$	424,817
Amortized intangible assets:
Other intangibles	253,087			247,712
Less: accumulated amortization	(105,989		)	(99,261		)
Net carrying amount	$	578,419		$	573,268

(a) The gross carrying value of trademarks and tradenames is reflected net of $60,202 of accumulated impairment charges.

Finite-lived Intangible Assets Amortization Expense

Amortization expense included in continuing operations was as follows:



	Three Months ended September 30,
	2017		2016
Amortization of intangible assets	$	4,911	$	4,728

Debt and Borrowings (Tables)

3 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Schedule of Debt and Borrowings

Debt and borrowings consisted of the following:



	September 30, 2017		June 30, 2017
Credit Agreement borrowings payable to banks	$	739,678	$	733,715
Tilda short-term borrowing arrangements	16,490		7,761
Other borrowings	8,455		8,672
	764,623		750,148
Short-term borrowings and current portion of long-term debt	18,231		9,844
Long-term debt, less current portion	$	746,392	$	740,304

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21521-112644

+ Details

Accumulated Other Comprehensive Income (Loss) (Tables)

3 Months Ended

Sep. 30, 2017

Equity [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The following tables present the changes in accumulated other comprehensive income (loss):



	Three Months Ended September 30,
	2017			2016
Foreign currency translation adjustments:
Other comprehensive income (loss) before reclassifications ⁽¹⁾	$	33,861		$	(31,736	)
Deferred gains/(losses) on cash flow hedging instruments:
Other comprehensive income before reclassifications	39			101
Amounts reclassified into income ⁽²⁾	(106		)	(496		)
Unrealized gain/(loss) on available for sale investment:
Other comprehensive loss before reclassifications	(7		)	(50		)
Amounts reclassified into income ⁽³⁾	—			10
Net change in accumulated other comprehensive income (loss)	$	33,787		$	(32,171	)


(1)	Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature and were a gain of $751 and a loss of $7,152 for the three months ended September 30, 2017 and 2016, respectively.


(2)	Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were $132 and $620 for the three months ended September 30, 2017 and 2016, respectively.

(3)

Stock-Based Compensation And Incentive Performance Plans (Tables)

3 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Compensation Cost And Related Income Tax Benefits Recognized

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Income for stock based compensation plans were as follows:



	Three Months Ended September 30,
	2017		2016
Compensation cost (included in selling, general and administrative expense)	$	3,164	$	2,704
Related income tax benefit	$	1,234	$	1,014

Summary Of Stock Option Activity

A summary of the stock option activity for the three months ended September 30, 2017 is as follows:



	Number of Options	Weighted Average Exercise Price		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
Options outstanding and exercisable at June 30, 2017	122	$	2.26
Exercised	—	$	—
Options outstanding and exercisable at September 30, 2017	122	$	2.26	13.8	$	4,742

Non-Vested Restricted Stock And Restricted Share Unit Awards

A summary of the restricted stock and restricted share unit activity for the three months ended September 30, 2017 is as follows:



	Number of Shares and Units		Weighted Average Grant Date Fair Value (per share)
Non-vested restricted stock, restricted share units, and performance units at June 30, 2017	992		$	27.59
Granted	352		$	32.75
Vested	(98	)	$	24.98
Forfeited	(4	)	$	33.95
Non-vested restricted stock, restricted share units, and performance units at September 30, 2017	1,242		$	29.24

Restricted Stock Grant Information



	Three Months Ended September 30,
	2017		2016
Fair value of restricted stock and restricted share units granted	$	11,516	$	—
Fair value of shares vested	$	4,019	$	2,926
Tax benefit recognized from restricted shares vesting	$	1,567	$	1,139

Financial Instruments Measured At Fair Value (Tables)

3 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Assets And Liabilities Measured At Fair Value On A Recurring Basis

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of September 30, 2017:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	7,658	$	7,658	$	—	$	—
Forward foreign currency contracts	66		—		66		—
Available for sale securities	872		872		—		—
	$	8,596	$	8,530	$	66	$	—
Liabilities:
Forward foreign currency contracts	217		—		217		—
Contingent consideration, current	2,853		—		—		2,853
Total	$	3,070	$	—	$	217	$	2,853

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2017:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	21,800	$	21,800	$	—	$	—
Forward foreign currency contracts	99		—		99		—
Available for sale securities	882		882		—		—
	$	22,781	$	22,682	$	99	$	—
Liabilities:
Forward foreign currency contracts	$	53	$	—	$	53	$	—
Contingent consideration, current	$	2,656	$	—	$	—	$	2,656
Total	$	2,709	$	—	$	53	$	2,656

Level 3 Activity

The following table summarizes the Level 3 activity for the three months ended September 30, 2017.



Balance as of June 30, 2017	$	2,656
Contingent consideration adjustment ^(a)	174
Translation adjustment	23
Balance as of September 30, 2017	$	2,853

Segment Information (Tables)

3 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.



	Three Months Ended September 30,
	2017			2016
Net Sales:
United States	$	263,659		$	254,232
United Kingdom	222,445			220,151
Hain Pure Protein	119,057			116,669
Rest of World	103,115			90,412
	$	708,276		$	681,464

Operating Income:
United States	$	20,861		$	18,794
United Kingdom	9,601			7,819
Hain Pure Protein	2,242			(1,018		)
Rest of World	8,997			5,055
	$	41,701		$	30,650
Corporate and Other ^(a)	(10,218		)	(16,899		)
	$	31,483		$	13,751

Schedule of Long-lived Assets

The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic area are as follows:



	September 30, 2017		June 30, 2017
United States	$	196,087	$	194,348
United Kingdom	169,054		165,396
All Other	69,710		63,330
Total	$	434,851	$	423,074

Net Sales Geographic Area

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as follows:



	Three Months Ended September 30,
	2017		2016
United States	$	397,351	$	385,768
United Kingdom	222,445		220,151
All Other	88,480		75,545
Total	$	708,276	$	681,464

Business (Details)	Sep. 30, 2017 country
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which entity operates (more than)	80

Basis of Presentation (Details) - USD ($) $ in Thousands	3 Months Ended
Basis of Presentation (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Sep. 30, 2016
Accounting Policies [Abstract]
Discrete tax benefit	$ 599
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in cash used in financing activities	$ 11,087	$ (11,589)
Accounting Standards Update 2016-09 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in cash used in financing activities		$ 405

Earnings Per Share (Computation Of Basic And Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Earnings Per Share [Abstract]
Net income	$ 19,846	$ 8,604
Denominator:
Basic weighted average shares outstanding (shares)	103,709	103,468
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units (shares)	767	738
Diluted weighted average shares outstanding (shares)	104,476	104,206
Net income per common share:
Basic (USD per share)	$ 0.19	$ 0.08
Diluted (USD per share)	$ 0.19	$ 0.08

Earnings Per Share (Narrative) (Details) - USD ($) shares in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 21, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Authorized amount			$ 250,000,000
Remaining authorized repurchase amount	$ 250,000,000
Stock Based Awards [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (shares)	573	277
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (shares)		4

Acquisitions (Details)				3 Months Ended
Acquisitions (Details)	Jun. 19, 2017 USD ($)	Apr. 28, 2017 GBP (£)	Apr. 28, 2017 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)
Business Acquisition [Line Items]
Acquisition related costs				$ 114,000	$ 253,000
Better Bean
Business Acquisition [Line Items]
Cash paid, net of cash acquired	$ 3,434,000
Contingent consideration, high range	$ 4,000,000
Contingent consideration arrangements, period for achievement operating results	3 years
Better Bean \| Sales
Business Acquisition [Line Items]
Concentration risk, percentage, less then				1.00%
Yorkshire Provender
Business Acquisition [Line Items]
Cash paid, net of cash acquired		£ 12,465,000	$ 16,110,000
Contingent consideration, high range \| £		£ 1,500,000
Contingent consideration arrangements, period for achievement operating results		3 years	3 years
Yorkshire Provender \| Sales
Business Acquisition [Line Items]
Concentration risk, percentage, less then				1.00%

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Inventory Disclosure [Abstract]
Finished goods	$ 295,794	$ 264,148
Raw materials, work-in-progress and packaging	188,998	163,160
Total inventories	$ 484,792	$ 427,308

Property, Plant And Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 637,265		$ 614,236
Less: Accumulated depreciation and amortization	256,787		243,725
Property, plant and equipment, net	380,478		370,511
Depreciation	10,295	$ 10,228
Land [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	34,556		33,930
Buildings and improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	118,553		116,723
Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	361,830		350,689
Computer hardware and software [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	52,740		51,486
Furniture and fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	16,480		15,993
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	30,199		29,296
Construction in progress [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 22,907		$ 16,119

Goodwill And Other Intangible Assets (Changes In Carrying Amount Of Goodwill) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Jun. 30, 2017
Goodwill
Goodwill	$ 1,059,981
Reallocation of goodwill between reporting units	0
Translation and other adjustments, net	13,700
Goodwill	1,073,681
Accumulated impairment losses	126,577	$ 126,577
United States [Member]
Goodwill
Goodwill	591,416
Reallocation of goodwill between reporting units	(35,519)
Translation and other adjustments, net	0
Goodwill	555,897
United Kingdom [Member]
Goodwill
Goodwill	329,135
Reallocation of goodwill between reporting units	35,519
Translation and other adjustments, net	10,785
Goodwill	375,439
Accumulated impairment losses	97,358	97,358
Hain Pure Protein [Member]
Goodwill
Goodwill	41,089
Reallocation of goodwill between reporting units	0
Translation and other adjustments, net	0
Goodwill	41,089
Rest of World [Member]
Goodwill
Goodwill	98,341
Reallocation of goodwill between reporting units	0
Translation and other adjustments, net	2,915
Goodwill	101,256
Europe [Member]
Goodwill
Accumulated impairment losses	$ 29,219	$ 29,219

Goodwill And Other Intangible Assets (Narrative) (Details) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017
Finite-Lived Intangible Assets [Line Items]
Impairment of intangible assets	$ 0	$ 0
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	3 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	25 years
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Impairment of intangible assets		14,079,000
Trade Names [Member] \| United Kingdom [Member]
Finite-Lived Intangible Assets [Line Items]
Impairment of intangible assets		7,579,000
Trade Names [Member] \| United States [Member]
Finite-Lived Intangible Assets [Line Items]
Impairment of intangible assets		$ 6,500,000

Goodwill And Other Intangible Assets (Components Of Trademarks And Other Intangible Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Indefinite-lived Intangible Assets [Line Items]
Trademarks and tradenames	$ 431,321	$ 424,817
Other intangibles	253,087	247,712
Less: accumulated amortization	(105,989)	(99,261)
Net carrying amount	578,419	573,268
Trademarks and Tradenames [Member]
Indefinite-lived Intangible Assets [Line Items]
Accumulated impairment charge	$ 60,202	$ 60,202

Goodwill And Other Intangible Assets (Amortization Expense) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 4,911	$ 4,728

Debt and Borrowings (Components of Debt) (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Line of Credit Facility [Line Items]
Other borrowings	$ 8,455	$ 8,672
Long-term debt	764,623	750,148
Short-term borrowings and current portion of long-term debt	18,231	9,844
Long-term debt, less current portion	746,392	740,304
Credit Agreement borrowings payable to banks [Member]
Line of Credit Facility [Line Items]
Line of credit facility	739,678	733,715
Tilda short-term borrowing arrangements [Member]
Line of Credit Facility [Line Items]
Line of credit facility	$ 16,490	$ 7,761

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References + Details

Debt and Borrowings (Narrative) (Details)		3 Months Ended
Debt and Borrowings (Narrative) (Details)	Dec. 12, 2014 USD ($)	Sep. 30, 2017 GBP (£)	Sep. 30, 2017 USD ($)	Sep. 30, 2017 EUR (€)
Line of Credit Facility [Line Items]
Line of credit potential incremental borrowing capacity post-amendment	$ 350,000,000
Revolving credit facility expiration date	Dec. 12, 2019
Interest Coverage Ratio	4.00
Leverage ratio	3.50
Consolidated leverage ratio	4.0
Credit Agreement [Member]
Line of Credit Facility [Line Items]
Revolving credit facility	$ 1,000,000,000
Borrowings outstanding under credit agreement			$ 739,678,000
Available borrowing capacity			$ 254,142,000
Weighted average interest rate		2.88%	2.88%	2.88%
Credit Agreement [Member] \| Minimum [Member]
Line of Credit Facility [Line Items]
Commitment fee percentage		0.20%
Credit Agreement [Member] \| Maximum [Member]
Line of Credit Facility [Line Items]
Commitment fee percentage		0.30%
Letter of Credit [Member]
Line of Credit Facility [Line Items]
Borrowings outstanding under credit agreement			$ 6,180,000
Eurocurrency Rate [Member] \| Minimum [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate		0.875%
Eurocurrency Rate [Member] \| Maximum [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate		1.70%
Base Rate [Member] \| Minimum [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate		0.00%
Base Rate [Member] \| Maximum [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate		0.70%
Tilda short-term borrowing arrangements [Member]
Line of Credit Facility [Line Items]
Revolving credit facility \| £		£ 52,000,000
Debt term		6 months
Short-term debt, weighted average interest rate		2.72%	2.72%	2.72%
Mona [Member]
Line of Credit Facility [Line Items]
Revolving credit facility \| €				€ 12,500,000
Basis spread on variable rate		1.10%
Short-term debt, weighted average interest rate		1.10%	1.10%	1.10%

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Sep. 30, 2016
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation	29.90%	8.30%
Impact of reduction in UK statutory tax rate		$ 2,086

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net change in accumulated other comprehensive income (loss)	$ 33,787,000	$ (32,171,000)
Foreign currency translation adjustments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	33,861,000	(31,736,000)
Deferred gains/(losses) on cash flow hedging instruments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	39,000	101,000
Amounts reclassified into income	(106,000)	(496,000)
Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments	132,000	620,000
Unrealized gain/(loss) on available for sale investment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	(7,000)	(50,000)
Amounts reclassified into income	0	10,000
Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments	0	(16,000)
Intra-entity foreign currency transactions [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	$ 751,000	$ (7,152,000)

Stock-Based Compensation And Incentive Performance Plans (Stock Plans Narrative) (Details)	3 Months Ended
	Sep. 30, 2017 USD ($) plan
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Number of plans \| plan	2
Unrecognized compensation expense \| $	$ 0

Stock-Based Compensation And Incentive Performance Plans (Compensation Cost And Related Income Tax Benefits Recognized) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Compensation cost (included in selling, general and administrative expense)	$ 3,164	$ 2,704
Related income tax benefit	$ 1,234	$ 1,014

Stock-Based Compensation And Incentive Performance Plans (Summary Of Stock Option Activity) (Details) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2017 USD ($) $ / shares shares
Number of Options
Options outstanding and exercisable at June 30, 2017 (shares) \| shares	122
Exercised (shares) \| shares	0
Options outstanding and exercisable at September 30, 2017 (shares) \| shares	122
Weighted Average Exercise Price
Options outstanding and exercisable at June 30, 2017 (USD per share) \| $ / shares	$ 2.26
Exercised (USD per share) \| $ / shares	0.00
Options outstanding and exercisable at September 30, 2017 (USD per share) \| $ / shares	$ 2.26
Weighted Average Contractual Life	165 months
Aggregate Intrinsic Value \| $	$ 4,742

Stock-Based Compensation And Incentive Performance Plans (Non-Vested Restricted Stock And Restricted Share Unit Awards) (Details) shares in Thousands	3 Months Ended
	Sep. 30, 2017 $ / shares shares
Number of Shares and Units
Non-vested restricted stock, restricted share units, and performance units at June 30, 2017 (shares) \| shares	992
Granted (shares) \| shares	352
Vested (shares) \| shares	(98)
Forfeited (shares) \| shares	(4)
Non-vested restricted stock, restricted share units, and performance units at September 30, 2017 (shares) \| shares	1,242
Weighted Average Grant Date Fair Value (per share)
Non-vested restricted stock, restricted share units, and performance units at June 30, 2017 (USD per share) \| $ / shares	$ 27.59
Granted (USD per share) \| $ / shares	32.75
Vested (USD per share) \| $ / shares	24.98
Forfeited (USD per share) \| $ / shares	33.95
Non-vested restricted stock, restricted share units, and performance units at September 30, 2017 (USD per share) \| $ / shares	$ 29.24

Stock-Based Compensation And Incentive Performance Plans (Restricted Stock Grant Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Fair value of restricted stock and restricted share units granted	$ 11,516	$ 0
Fair value of shares vested	4,019	2,926
Tax benefit recognized from restricted shares vesting	$ 1,567	$ 1,139

Stock-Based Compensation And Incentive Performance Plans (CEO July 2012 Grant) (Details) $ / shares in Units, $ in Thousands		3 Months Ended
	Jul. 03, 2012 USD ($) tranche target $ / shares shares	Sep. 30, 2017 USD ($) condition	Sep. 30, 2016 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted stock and restricted share units granted \| $		$ 11,516	$ 0
Nonvested awards compensation expense not yet recognized \| $		$ 19,737
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Weighted Average Period to Recognize Expense		23 months
CEO [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Total Shares (shares) \| shares	800,000
Number of share price targets \| target	4
Consecutive trading days	45 days
Vesting period	5 years
Fair value of restricted stock and restricted share units granted \| $	$ 16,151
CEO Grant July 2012 Weighted Average Period to Recognize Expense	4 years
Number of market conditions \| condition		4
Number of tranches \| tranche	4
CEO [Member] \| Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Total Shares (shares) \| shares	200,000
CEO Grant July 2012 Market Price Target (USD per share)	$ 31.25
CEO [Member] \| Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Market Price Target (USD per share)	36.25
CEO [Member] \| Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Market Price Target (USD per share)	41.25
CEO [Member] \| Tranche Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 Market Price Target (USD per share)	$ 50

Stock-Based Compensation And Incentive Performance Plans (Long-Term Incentive Plan) (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Other labor-related expenses	$ 546	$ 1,127
Long Term Incentive Plan 2015-2016 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award requisite service period	2 years
Long Term Incentive Plan 2016-2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award requisite service period	3 years
Conversion of common stock (in shares)			1

Investments And Joint Ventures (Equity Method Investments) (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017	Oct. 27, 2015
Hutchison Hain Organic Holdings Limited [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage	50.00%	50.00%
Advances to affiliate	$ 1,975	$ 1,629
Chop't [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage			14.90%
Equity method investments	$ 16,262	$ 16,487
Ownership percentage diluted basis	11.90%

Investments And Joint Ventures (Available for Sale Securities) (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2017	Jun. 30, 2017
Equity Method Investments and Joint Ventures [Abstract]
Equity ownership interest percentage, less than	1.00%
Shares held (in shares)	933
Available for sale securities	$ 872	$ 882
Amortized cost basis	$ 1,164	$ 1,164

Financial Instruments Measured At Fair Value (Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Assets:
Cash equivalents	$ 7,658	$ 21,800
Forward foreign currency contracts	66	99
Available for sale securities	872	882
Assets total	8,596	22,781
Liabilities:
Forward foreign currency contracts	217	53
Contingent consideration, current	2,853	2,656
Liabilities total	3,070	2,709
Quoted Prices In Active Markets (Level 1) [Member]
Assets:
Cash equivalents	7,658	21,800
Forward foreign currency contracts	0	0
Available for sale securities	872	882
Assets total	8,530	22,682
Liabilities:
Forward foreign currency contracts	0	0
Contingent consideration, current	0	0
Liabilities total	0	0
Significant Other Observable Inputs (Level 2) [Member]
Assets:
Cash equivalents	0	0
Forward foreign currency contracts	66	99
Available for sale securities	0	0
Assets total	66	99
Liabilities:
Forward foreign currency contracts	217	53
Contingent consideration, current	0	0
Liabilities total	217	53
Significant Unobservable Inputs (Level 3) [Member]
Assets:
Cash equivalents	0	0
Forward foreign currency contracts	0	0
Available for sale securities	0	0
Assets total	0	0
Liabilities:
Forward foreign currency contracts	0	0
Contingent consideration, current	2,853	2,656
Liabilities total	$ 2,853	$ 2,656

Financial Instruments Measured At Fair Value (Summary Of Level 3 Activity) (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2017 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance as of June 30, 2017	$ 2,656
Contingent consideration adjustment	174
Translation adjustment	23
Balance as of September 30, 2017	$ 2,853

Financial Instruments Measured At Fair Value (Narrative) (Details) - USD ($)	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of foreign exchange hedges discontinued	$ 0	$ 0
Cash Flow Hedging [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount			$ 1,828,000
Fair value amounts of derivative contracts, net assets (liabilities)			84,000
Fair Value Hedging [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	6,000,000
Fair value amounts of derivative contracts, net assets (liabilities)	(46,000)
Fair Value Hedging [Member] \| Not Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	13,200,000		6,114,000
Fair value amounts of derivative contracts, net assets (liabilities)	$ (105,000)		$ (38,000)

Commitments And Contingencies (Details) - complaint				1 Months Ended
Commitments And Contingencies (Details) - complaint	Oct. 03, 2017	Apr. 26, 2017	Aug. 17, 2016	Dec. 29, 2016
Securities Complaints [Member]
Loss Contingencies [Line Items]
Number of complaints			3
Securities Complaints [Member] \| Subsequent Event [Member]
Loss Contingencies [Line Items]
Period required to file reply	45 days
Derivative Complaints [Member]
Loss Contingencies [Line Items]
Number of complaints				2
Barnes Complaint [Member]
Loss Contingencies [Line Items]
Number of complaints		2

Segment Information (Segment Data) (Details) $ in Thousands	3 Months Ended		12 Months Ended
Segment Information (Segment Data) (Details) $ in Thousands	Sep. 30, 2017 USD ($) segment	Sep. 30, 2016 USD ($)	Jun. 30, 2016 segment
Segment Reporting Information [Line Items]
Number of operating segments \| segment	9		8
Net sales	$ 708,276	$ 681,464
Operating Income	31,483	13,751
Acquisition related expenses, restructuring and integration charges	4,488	6,421
Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales	708,276	681,464
Operating Income	41,701	30,650
Operating Segments [Member] \| United States [Member]
Segment Reporting Information [Line Items]
Net sales	263,659	254,232
Operating Income	20,861	18,794
Operating Segments [Member] \| United Kingdom [Member]
Segment Reporting Information [Line Items]
Net sales	222,445	220,151
Operating Income	9,601	7,819
Operating Segments [Member] \| Hain Pure Protein [Member]
Segment Reporting Information [Line Items]
Net sales	119,057	116,669
Operating Income	2,242	(1,018)
Operating Segments [Member] \| Rest of World [Member]
Segment Reporting Information [Line Items]
Net sales	103,115	90,412
Operating Income	8,997	5,055
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Operating Income	$ (10,218)	$ (16,899)

Segment Information (Long-lived Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Segment Reporting Information [Line Items]
Long-lived assets	$ 434,851	$ 423,074
United States [Member]
Segment Reporting Information [Line Items]
Long-lived assets	196,087	194,348
United Kingdom [Member]
Segment Reporting Information [Line Items]
Long-lived assets	169,054	165,396
All Other [Member]
Segment Reporting Information [Line Items]
Long-lived assets	$ 69,710	$ 63,330

Segment Information (Net Sales) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 708,276	$ 681,464
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	397,351	385,768
United Kingdom [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	222,445	220,151
All Other [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 88,480	$ 75,545